Literature DB >> 9536231

The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire.

V Lawson1, M S Lewis-Jones, A Y Finlay, P Reid, R G Owens.   

Abstract

Little information is available about the effect of childhood atopic dermatitis (AD) on family function. The aim of this study was to identify the areas of family life most affected and their perceived importance. Intensive qualitative interviews with 34 families were conducted and 11 basic problem areas were identified. A detailed questionnaire was prepared, part of which addressed the perceived importance of particular issues using the framework of multi-attribute utility theory. The results from using this questionnaire in 41 families were analysed and a shorter 10-question one-page Dermatitis Family Impact (DFI) questionnaire designed (maximum score = 30). In affected families the mean DFI score was 9.6 +/- 7.0 (range 0-27, n = 56) and in unaffected families the mean score was 0.4 +/- 0.9 (range 0-3, n = 26, P < 0.0001). The DFI could potentially be used as an extra measure in clinical studies, or to help guide appropriate management of AD.

Entities:  

Mesh:

Year:  1998        PMID: 9536231     DOI: 10.1046/j.1365-2133.1998.02034.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  56 in total

1.  The quality of life of parents of children with atopic dermatitis: interpretation of PIQoL-AD scores.

Authors:  D M Meads; S P McKenna; K Kahler
Journal:  Qual Life Res       Date:  2005-12       Impact factor: 4.147

Review 2.  Quality-of-life outcomes and measurement in childhood atopic dermatitis.

Authors:  Sarah L Chamlin; Mary-Margaret Chren
Journal:  Immunol Allergy Clin North Am       Date:  2010-07-01       Impact factor: 3.479

3.  Oral and Topical Antibiotics for Clinically Infected Eczema in Children: A Pragmatic Randomized Controlled Trial in Ambulatory Care.

Authors:  Nick A Francis; Matthew J Ridd; Emma Thomas-Jones; Christopher C Butler; Kerenza Hood; Victoria Shepherd; Charis A Marwick; Chao Huang; Mirella Longo; Mandy Wootton; Frank Sullivan
Journal:  Ann Fam Med       Date:  2017-03       Impact factor: 5.166

4.  Effects of probiotics on atopic dermatitis: a randomised controlled trial.

Authors:  S Weston; A Halbert; P Richmond; S L Prescott
Journal:  Arch Dis Child       Date:  2005-04-29       Impact factor: 3.791

Review 5.  Condition-specific quality of life questionnaires for caregivers of children with pediatric conditions: a systematic review.

Authors:  Maria Yui Kwan Chow; Angela M Morrow; Spring Chenoa Cooper Robbins; Julie Leask
Journal:  Qual Life Res       Date:  2013-01-06       Impact factor: 4.147

6.  International development of the Parents' Index of Quality of Life in Atopic Dermatitis (PIQoL-AD).

Authors:  Stephen P McKenna; Diane Whalley; Abigail L Dewar; Ruud A M Erdman; Thomas Kohlmann; Mauro Niero; Eva Baró; Sharon A Cook; Beatrice Crickx; Feride Frech; Daniel van Assche
Journal:  Qual Life Res       Date:  2005-02       Impact factor: 4.147

Review 7.  Efficacy of health education on treatment of children with atopic dermatitis: a meta-analysis of randomized controlled trials.

Authors:  Yunling Li; Ting Han; Wei Li; Yin Li; Xiaoxuan Guo; Lei Zheng
Journal:  Arch Dermatol Res       Date:  2020-04-15       Impact factor: 3.017

Review 8.  Stress and atopic dermatitis.

Authors:  Jenna Arndt; Nananamibia Smith; Francisco Tausk
Journal:  Curr Allergy Asthma Rep       Date:  2008-07       Impact factor: 4.806

Review 9.  Educational paper: parenting a child with a disfiguring condition-how (well) do parents adapt?

Authors:  Willem H Leemreis; Jolanda M E Okkerse; Peter C J de Laat; Gerard C Madern; Léon N A van Adrichem; Frank Verhulst; Arnold P Oranje
Journal:  Eur J Pediatr       Date:  2013-06-18       Impact factor: 3.183

Review 10.  Cost of illness of atopic dermatitis in children: a societal perspective.

Authors:  Andrew S Kemp
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.